EXALIN Launching Presentation
-
Upload
subrata-roy -
Category
Marketing
-
view
133 -
download
2
Transcript of EXALIN Launching Presentation
![Page 1: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/1.jpg)
1
Subrata RoySr.Product Executive, PMDCell:01713-374737
![Page 2: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/2.jpg)
Total antihistamine market in Bangladesh
2
293.60 Cr.
IMS-1st Qtr-2015-MAT
![Page 3: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/3.jpg)
3
Generic Yearly Value CETIRIZINE 68.79 cr.
FEXOFENADINE 64.60 cr. KETOTIFEN 60.63 cr.
RUPATADINE 24 cr. DESLORATADINE 20 .64 cr. LEVOCETIRIZINE 14 .71 cr.
EBASTINE 12 .58 cr. LORATADINE 11.19 cr.
CHLORPHENAMINE 10.84 cr. HYDROXYZINE 5.54 cr.
IMS-1st Qtr-2015-MAT
![Page 4: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/4.jpg)
4
CETIRIZINE23%
FEXOFENADINE22%
KETOTIFEN21%
RUPATADINE8%
DESLORATADINE7%
LEVOCET-IRIZINE
5%
EBASTINE4%
LO-RATA-DINE4%
CHLORPHENAMINE4%
HYDROXYZINE2%
Value share (%) of various generic in Antihistamine market IMS-1st Qtr-2015-
MAT
![Page 5: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/5.jpg)
5
RUPATADINE
LEVOCETIRIZINE
HYDROXYZINE
FEXOFENADINE
DESLORATADINE
EBASTINE
KETOTIFEN
CETIRIZINE
CHLORPHENAMINE
0.00 10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00
67.93
48.77
27.77
15.45
11.54
10.52
10.29
3.47
0.82
Growth of Antihistamine market(%)
growth IMS-1st Qtr-2015-MAT
![Page 6: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/6.jpg)
6
Market Scenario of RupatadineTotal Market: 24 Cr. (67.93% growth)
Ref: IMS_1st quarter_MAT_2015
Brand CompanyValue (Cr.)/
Month
Value (Cr.)/ year
Growth(%)
RUPA Aristopharma .73 8.76 26.57
RUPADIN Beacon .27 3.23 17.95
MINISTA Radiant .26 3.14 999.00
DIPA Drug Intl. .18 2.17 81.15
RUPIN Ziska .15 1.88 59.98
RUPATROL Square .10 1.20 29.19
![Page 7: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/7.jpg)
7
Brand Company NAT Sh.
RUPA Aristopharma 23.48RUPIN Ziska 17.81Minista RADIANT 10.12
DIPA Drug International 9.72RUPADIN Beacon 9.31Rosela Healthcare 8.10
Rupenta Orion Pharma 5.67Rupaday Eskayef Bangladesh Ltd. 3.64
Prescription Scenario
Ref: 4PMay’15[Product Share]
![Page 8: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/8.jpg)
8
Disease Profile
![Page 9: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/9.jpg)
9
Disease Profile
Seasonal & perennial allergic rhinitis
Chronic & acute urticariaPollinosisAllergic dermatitisAllergic conjunctivitis
![Page 10: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/10.jpg)
10
What is allergic rhinitis?
Ans.Allergic rhinitis is an inflammation of the tissues inside the nose. It causes sneezing, runny nose and stuffy nose. It is often accompanied by conjunctivitis (itchy, watery eyes). Most often it is caused by an allergy or an infection.
What is polinosis?
Ans.It is an allergy caused by pollen or dust in which the mucous membranes of the eyes and nose are itchy and inflamed, causing a runny nose and watery eyes.
What is urticaria ?Ans. Urticaria is a common debilitating skin disorder that is characterized by wheals, flare/erythema and pruritus, and is often accompanied by angio-edema. Historically, the etiology of the disorder has been poorly defined and this has led to it being referred to as chronic idiopathic urticaria in many instances.
![Page 11: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/11.jpg)
11
What is Allergic dermatitis ?Ans.It is a form of contact dermatitis that is the manifestation of an allergic response caused by contact with a substance
What is Allergic conjunctivitis?Ans.It is an inflammation of the conjunctiva (the membrane covering the white part of the eye) due to allergy
![Page 12: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/12.jpg)
Treatment option
12
![Page 13: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/13.jpg)
Limitations & Opportunity
Allergic rhinitis or allergic symptoms (e.g. Nasal congestion, nasal rhinorrhea, nasal itching & sneezing attacks) require quick relief. But, all antihistamines are not able to show quick relief or rapid onset of action -
13
![Page 14: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/14.jpg)
To overcome this limitationOpso Saline introduces
14
Brings back allergy free lively life 10 mg
tablet
![Page 15: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/15.jpg)
At a glanceBrand Exalin TabletGeneric & strength Rupatadine 10 mg
Pack size 10x3Dosage form TabletJustification of brand name
Excellent allergic inhibition
Price 300 BDT /Pack; 10 BDT/ Unit
Pregnancy category • US FDA : C• TGA, Australia : B2
Nursing mothers: Benefit to risk ratioMajor indication Seasonal & perennial allergic rhinitis
Chronic & acute urticaria Pollinosis Allergic dermatitis Allergic conjunctivitis
Dose Once Daily 15
![Page 16: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/16.jpg)
Promotional Support
•Literature•Gift •Sample*All promo items will be available before product launching
16
![Page 17: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/17.jpg)
Discussion on Literature
17
![Page 18: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/18.jpg)
18
Sir,in this visual you can see- a fielder is missed a catch due to lack of swiftness & promptness which may lead to loss the match.
Like that for the treatment of allergic symptoms require prompt acting Antihistamine(A fielder like Jonty Rhodes)
But, conventional antihistamine do not able to minimize allergic symptoms due to delayed onset
![Page 19: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/19.jpg)
19
![Page 20: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/20.jpg)
20
![Page 21: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/21.jpg)
21
![Page 22: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/22.jpg)
22
![Page 23: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/23.jpg)
23
![Page 24: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/24.jpg)
24
![Page 25: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/25.jpg)
25
01 02
03 04At a
glance
![Page 26: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/26.jpg)
Target doctor & market ENTGPMedicinePCSurgeryOphthalmologist
26
RUPARUPINMinistaDIPARUPADIN
![Page 27: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/27.jpg)
27
Some definitions for Rupatadine Mechanism of action
![Page 28: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/28.jpg)
28
What is Platelet-activating factor (PAF)?
Platelet-activating factor (PAF) is a lipid mediator that is well-known for its ability to cause platelet aggregation, inflammation, and allergic response. PAF is released by many different cells, including eosinophils, mast cells, neutrophils, monocytes, macrophages and endothelial cells.
What is eosinophil?Ans .Eosinophils are a type of disease-fighting white blood cell. High levels of eosinophils may also occur in your body's tissues at the site of an infection or inflammation (tissue eosinophilia).
What is chemotaxis?Ans.Movement of a cell toward or away from a chemical substance
What is CytokineAns.Molecule that controls reactions among cells; key component of inflammation
What is NeutrophilAns.It is a type of leukocyte (white blood cell) that travels through the blood to an injured or inflamed site via a process called chemotaxis
What is Adhesion MoleculeAns.Any of a large number of cell-surface molecules of several different classes that affect the attachment of one cell to another
![Page 29: EXALIN Launching Presentation](https://reader035.fdocuments.in/reader035/viewer/2022062223/587787bc1a28abc85f8b6bf7/html5/thumbnails/29.jpg)
Thanks for your kind support
29